Trends and advances in the diagnosis and control of paratuberculosis in domestic livestock. Issue 4 (1st October 2016)

• Record Type: Journal Article
• Authors: Chaubey, Kundan Kumar; Gupta, Rinkoo Devi; Gupta, Saurabh; Singh, Shoor Vir; Bhatia, Ashok Kumar; Jayaraman, Sujata; Kumar, Naveen; Goel, Anjana; Rathore, Abhishek Singh; Sahzad, ; Sohal, Jagdip Singh; Stephen, Bjorn John; Singh, Manju; Goyal, Manish; Dhama, Kuldeep; Derakhshandeh, Abdollah
• Is Part Of: Veterinary quarterly. Volume 36:Issue 4(2016)
• Page Start: 203
• Page End: 227
• Publication Date: 2016-10-01
• Subjects: Cattle -- paratuberculosis -- Johne's disease -- Mycobacterium avium subsp. paratuberculosis -- secretory proteins -- review; Veterinary medicine -- Periodicals; Veterinary Medicine; Veterinary medicine -- Periodicals; Veterinary research -- Periodicals; Veterinary medicine; Periodicals; Periodicals; 636.089
• DOI: 10.1080/01652176.2016.1196508
• Languages: English
• ISSNs: 0165-2176

Abstract

ABSTRACT: Paratuberculosis (pTB) is a chronic granulomatous enteritis caused by Mycobacterium avium subsp. paratuberculosis (MAP) in a wide variety of domestic and wild animals. Control of pTB is difficult due to the lack of sensitive, efficacious and cost-effective diagnostics and marker vaccines. Microscopy, culture, and PCR have been used for the screening of MAP infection in animals for quite a long time. Besides, giving variable sensitivity and specificity, these tests have not been considered ideal for large-scale screening of domestic livestock. Serological tests like ELISA easily detects anti-MAP antibodies. However, it cannot differentiate between the vaccinated and infected animals. Nanotechnology-based diagnostic tests are underway to improve the sensitivity and specificity. Newer generation diagnostic tests based on recombinant MAP secretory proteins would open new paradigm for the differentiation between infected and vaccinated animals and for early detection of the infection. Due to higher seroreactivity of secretory proteins vis-à-vis cellular proteins, the secretory proteins may be used as marker vaccine, which may aid in the control of pTB infection in animals. Secretory proteins can be potentially used to develop future diagnostics, surveillance and monitoring of the disease progression in animals and the marker vaccine for the control and eradication of pTB.